Human Oncology & Pathogenesis Program
The Sarat Chandarlapaty Lab
Research

My lab focuses on understanding the regulation of growth factor signal transduction pathways that are aberrantly activated in cancers, with a focus on those implicated in breast cancer pathogenesis.

Featured News
Publications
People

Sarat Chandarlapaty, MD, PhD
- Physician-scientist Sarat Chandarlapaty studies the regulation of growth factor signaling networks in cancer.
- MD, Wake Forest School of Medicine
- PhD, University of North Carolina
- [email protected]
- Email Address
- View physician profile
- Physician profile
Members











Research Technician

Graduate Student

Research Scholar



Research Fellow

Research Associate
Graduate Student

Research Technician Sr.

Graduate Student

Research Fellow



- The College of New Jersey



Lab Alumni

Research Technician

Graduate Student

Scientist at University of California Los Angeles, Los Angeles, CA

Research Fellow

Research Secretary

Research Fellow

Research Technician

Graduate Research Assistant
Lab Affilations
Achievements
- Clinical Investigator Award, Damon Runyon Cancer Research Foundation (2012)
- Young Investigator Award, American Society of Clinical Oncology (2007)
- Fellow in Biomedical Research, The Dana Foundation (2006)
Open Positions
Career Opportunities
Get in Touch
-
Lab Head Email
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Sarat Chandarlapaty discloses the following relationships and financial interests:
-
Breast Cancer Research Foundation
Provision of Services -
Bristol-Myers Squibb
Provision of Services -
Eli Lilly and Company
Provision of Services -
Global Breast Cancer Conference
Provision of Services -
National Comprehensive Cancer Network
Provision of Services
-
Novartis
Provision of Services -
Paige.AI, Inc.
Provision of Services -
Revolution Medicines
Provision of Services -
Sermonix Pharmaceuticals, LLC
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].